WATERTOWN, Mass., July 29, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing […]
(All amounts in U.S. dollars.Per share information based on dilutedshares outstanding unless otherwise noted.)TORONTO, July 29, 2020 (GLOBE NEWSWIRE) — […]